The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term outcomes of PD-1 blockade in metastatic or unresectable cutaneous squamous cell cancer.
 
Shawn Ahmed Ali
No Relationships to Disclose
 
Erin Elizabeth McGillivray
No Relationships to Disclose
 
David James Savage
No Relationships to Disclose
 
Kathryn Blount Bollin
Consulting or Advisory Role - Iovance Biotherapeutics; Nektar
 
Mark Swanson
No Relationships to Disclose
 
Niels Kokot
No Relationships to Disclose
 
Jenny Hu
No Relationships to Disclose
 
Fumito Ito
No Relationships to Disclose
 
Gino Kim In
Honoraria - Array BioPharma/Pfizer; Bristol-Myers Squibb; regeneron; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Novartis; Sanofi
Speakers' Bureau - Merck; Regeneron; Rockpointe CME; Targeted Oncology
Research Funding - Checkmate Pharmaceuticals (Inst); Idera (Inst); Instil Bio (Inst); Regeneron (Inst); Replimune (Inst); Xencor (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Pfizer; Regeneron